Valuation Vertex Pharmaceuticals Incorporated Sao Paulo

Stocks

Market Closed - Sao Paulo 15:16:17 19/10/2026 BST			5-day change	1st Jan Change
79.36 ^BRL	-0.30%		+3.77%	+1.43%

10-20	Vertex Pharmaceuticals Incorporated Announces Appointment of Daniel Brennan as Member of the Board of Directors, Audit and Finance Committee	CI
10-15	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	130,444	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	13.4%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	124,711	122,900	121,943
Change	-	31.13%	47.8%	4.23%	11.09%	15.03%	-1.45%	-0.78%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	35x	28.2x	23.3x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	8.51x	6.75x	5.48x
PEG	-	0.5x	3.51x	2x	-0x	-16.31x	1.2x	1.1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.83x	8.96x	7.89x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.4x	8.44x	7.37x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	28.1x	19.7x	17x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	22.3x	20.1x	16.9x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	69.1x	25.9x	23.6x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	1.45%	3.86%	4.24%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	14.99	18.62	22.56
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,269	14,565	16,542
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	4,443	6,248	7,186
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,583	6,114	7,228
Net income ¹	2,342	3,322	3,620	-535.6	3,953	3,891	4,892	5,868
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-5,733	-7,544	-8,501
Reference price ²	219.60	288.78	406.89	402.70	453.36	524.52	524.52	524.52
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,144B
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	625B
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	511B
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	377B
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	366B
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	291B
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	262B
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	237B
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	194B
Average	29.64x	7.05x	18.73x	2.12%	445.32B
Weighted average by Cap.	35.48x	8.34x	20.49x	1.8%